Adults with attention deficit/hyperactivity disorder (ADHD) often present psychiatric
comorbidities and, in particular, substance use disorder (SUD). ADHD-SUD comorbidity is …

Using cannabis to reduce psychological and physical distress, referred to as self-
medication, is a significant risk factor for cannabis use disorder. To better understand this …

Adults with ADHD describe self-medicating with cannabis, with some reporting a preference
for cannabis over ADHD medications. A small number of psychiatrists in the US prescribe …

Objective: The objective of the study is to explore the role and possible substance
preference in ADHD and subtypes in substance use disorder (SUD). Method: Using self …

Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing neurodevelopmental
disorder with a prevalence of 5% in children and adolescents and of 2.5% in adults …

Conclusions The information provided will help physicians assess a situation in which the
risk–benefit ratio to the patient and the doctor as well should be carefully weighed. Finally, it …

The current study aimed to explore the multimodal differences between the inattentive
ADHD (ADHD-I) subtype and the combined ADHD (ADHD-C) subtype. A large sample of …

Objective: To estimate the prevalence of ADHD and determine an effective screening test for
ADHD in a population-seeking treatment for cannabis use disorders. Method: The Conners …

Despite the evidence for altered decision making in cannabis abusers, the role of the
cannabinoid system in decision-making circuits has not been studied. Here, we examined …

Objective: To evaluate the associations between cannabis use and neurocognitive
functioning, including self-reported attention deficit hyperactivity disorder (ADHD) symptoms …